• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Can Maternal Vitamin C Supplements Increase Airway Function in Infants Born to Mothers Who Smoke?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Daily vitamin C supplementation in pregnant smokers has been shown to increase newborn pulmonary function and infant forced expiratory flows (FEFs) at 3 months
  • McEvoy et al. (European Respiratory Journal, 2020) assessed whether vitamin C supplementation in pregnant smokers was associated with improved airway function in their infants through 12 months of age

METHODS:

  • Secondary outcome of a randomized, double-blind, placebo-controlled trial
  • Participants
    • Pregnant smokers between 13 and 23 weeks of gestation
  • Interventions
    • Vitamin C: 125 to 500 mg/day
    • Placebo
  • Study design
    • Participants were also provided with smoking cessation counseling
    • FEFs performed at 3 and 12 months of age

RESULTS:

  • 222 infants examined at 3 months | 202 infants examine at 12 months
  • While overall characteristics were similar between groups, women in the Vitamin C treatment group had significantly higher fasting ascorbic acid levels at mid (p<0.001) and late gestation (p<0.001)
  • Compared to placebo, infants born to mothers in the vitamin C group had significantly increased FEFs over the first year of life
  • Overall increased flows between 3 and 12 months
    • FEF75: 40.2 mL/sec (95% CI, 6.6 to 73.8; p = 0.025) | 16.1% effective increase
    • FEF50: 58.3 mL/sec (95% CI, 10.9 to 105.8; p = 0.0081) | 11.6% effective increase
    • FEF25 to 75: 55.1 mL/sec (95% CI, 9.7 to 100.5; p = 0.013) | 12% effective increase

CONCLUSION:

  • Infants born to smokers who took a vitamin C supplement every day had small but significant increased airway function at 3 and 12 months of age, compared to infants born to smokers who did not supplement
  • The study was underpowered to assess clinical outcomes such as wheezing
  • The research team will be continuing the study to 5 years of age
  • The authors state that while the main goal should always be smoking cessation

This study demonstrates that the safe, inexpensive and simple intervention of vitamin C supplementation can persistently improve the airway function of infants exposed to in utero smoke

Learn More – Primary Sources:

Vitamin C to Pregnant Smokers Persistently Improves Infant Airway Function to 12 Months of Age: A Randomised Trial

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Does Smoking During Pregnancy Affect the Fetal Immune System?
Increasing the Folic Acid Dose for Women Who Smoke: Does it Reduce the Risk of Fetal Growth Restriction?
Safe Passage Study: Prenatal Alcohol Exposure and Cognitive Abilities at 4 years of Age

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site